Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Open Access
- 20 June 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 36 (4), 343-348
- https://doi.org/10.1038/sj.bmt.1705034
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donorsBone Marrow Transplantation, 2003
- Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in JapanBone Marrow Transplantation, 2003
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseBlood, 2002
- A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host diseaseBone Marrow Transplantation, 2001
- Successful Use of Extracorporeal Photochemotherapy in the Treatment of Severe Acute and Chronic Graft-Versus-Host DiseaseBlood, 1998
- Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcomeBlood, 1990
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseBlood, 1988
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationBlood, 1988
- Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 seattle patientsAmerican Journal Of Medicine, 1980
- Bone-Marrow TransplantationThe New England Journal of Medicine, 1975